Grant: Discovery Grants Program - Individual
University of Waterloo
$33,000.00
Engineering Bacteria-Responsive Intravaginal Rings for Controlled Drug Delivery
FY 2024-25
Summary
Major advantage of implants is their ability to provide long-term drug delivery. Current intravaginal implants such as intravaginal rings (IVRs) and intrauterine devices rely on simple drug diffusion for drug delivery. The method of fabrication results in a matrix-based system that only allows diffusion of small molecule drugs from the polymer. Based on these current designs, it would not be possible to deliver nucleic acids, proteins/peptides, or nanocarrier systems from the implant systems. A major challenge in the materials science field is the development of precisely tuned stimuli-responsive drug delivery systems that can produce predictable drug release rates. As a result, the proposed research program is focused on the development of advanced biomaterials for the fabrication of bacteria-responsive IVRs that will provide controlled sustained delivery of antibiotic-encapsulated nanoparticles for >14 days. Initial focus will be on the fabrication of IVRs synthesized from novel polyurethane composite biomaterials that alter its composition in the presence of specific bacterial enzymes. These IVRs are designed to respond to changes to the microflora environment of the female genital tract e.g. little to no drug release at normal physiological conditions and rapid drug release when specific enzymes are released by foreign bacteria. Physical-chemical characterization of the newly synthesized biomaterials will be performed to determine properties such as melting temperature, porosity, shore hardness, etc. The influence of these various properties on the structural features of the fabricated IVRs and its impact on the release profile of antibiotic-encapsulated nanoparticles will also be investigated. The implant drug delivery system will be evaluated for biocompatibility, its ability to release drug in the presence of specific bacteria, long-term stability, and efficacy in reducing bacterial growth. Overall, the proposed research program is innovative and will significantly contribute to the advancement of knowledge in the field of materials science, via the generation of novel bacteria-responsive polyurethane composite biomaterials for the controlled delivery of nanoparticles. Most importantly, highly qualified personnel trained in this research program will acquire the necessary knowledge and skills to be leaders in the fields of biopolymers, materials engineering, and drug delivery.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2021-03072
Name nom
Ho, Emmanuel
Department département
Pharmacy, School of - Pharmacy, School of
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2021
Award amount
33000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1208
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Materials sciences
Area of application fr
Sciences des matériaux
Research subject code
2004
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Polymers and coatings
Research subject fr
Polymères et revêtements
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Engineering Bacteria-Responsive Intravaginal Rings for Controlled Drug Delivery
Keywords
intravaginal rings; controlled drug delivery; polyurethane; bacteria-responsive; polymers; biomaterials; nanoparticles; antibiotics
Application summary
Major advantage of implants is their ability to provide long-term drug delivery. Current intravaginal implants such as intravaginal rings (IVRs) and intrauterine devices rely on simple drug diffusion for drug delivery. The method of fabrication results in a matrix-based system that only allows diffusion of small molecule drugs from the polymer. Based on these current designs, it would not be possible to deliver nucleic acids, proteins/peptides, or nanocarrier systems from the implant systems. A major challenge in the materials science field is the development of precisely tuned stimuli-responsive drug delivery systems that can produce predictable drug release rates. As a result, the proposed research program is focused on the development of advanced biomaterials for the fabrication of bacteria-responsive IVRs that will provide controlled sustained delivery of antibiotic-encapsulated nanoparticles for >14 days. Initial focus will be on the fabrication of IVRs synthesized from novel polyurethane composite biomaterials that alter its composition in the presence of specific bacterial enzymes. These IVRs are designed to respond to changes to the microflora environment of the female genital tract e.g. little to no drug release at normal physiological conditions and rapid drug release when specific enzymes are released by foreign bacteria. Physical-chemical characterization of the newly synthesized biomaterials will be performed to determine properties such as melting temperature, porosity, shore hardness, etc. The influence of these various properties on the structural features of the fabricated IVRs and its impact on the release profile of antibiotic-encapsulated nanoparticles will also be investigated. The implant drug delivery system will be evaluated for biocompatibility, its ability to release drug in the presence of specific bacteria, long-term stability, and efficacy in reducing bacterial growth. Overall, the proposed research program is innovative and will significantly contribute to the advancement of knowledge in the field of materials science, via the generation of novel bacteria-responsive polyurethane composite biomaterials for the controlled delivery of nanoparticles. Most importantly, highly qualified personnel trained in this research program will acquire the necessary knowledge and skills to be leaders in the fields of biopolymers, materials engineering, and drug delivery.